Grand Strand Clinical Trial Services, LLC

Following up our Trivia Tuesday post about gene therapy... there are a lot of recent advancements in gene therapy. 🔬 Check out this article recently posted about a study out of the Karolinska Institute in which gene therapy has been found to be effective in patients with Bothnia dystrophy (a form of hereditary blindness). For more information, be sure to read the full publication at: https://lnkd.in/gngfKJaR #genetherapy #innovation #clinicalresearch #clinicaltrials #Bothniadystrophy #GSCTS #GSClinical

The answer to yesterday's Trivia Tuesday is ... 🥁🥁 🥁 ... The first rare disease to be successfully treated with gene therapy was ... C) severe combined immunodeficiency (SCID)! Stay tuned next week for more fun trivia! #TriviaTuesday #TuesdayTrivia #ClinicalResearch #genetherapy #raredisease #themoreyouknow #GSCTS #GSClinical

There is still time to submit a meeting request for FDA consideration in the CID Paired Meeting Program. September 30th and December 31st are the last 2 slots in 2024. We can help you take advantage of this opportunity for increased interaction with the Agency. Let's talk!

🤔 IT'S TRIVIA TUESDAY AGAIN! 🤔 With gene therapy approvals rising, let's test your gene therapy knowledge. QUESTION: What was the first rare disease to be successfully treated with gene therapy? A) sickle cell disease B) hemophilia C) severe combined immunodeficiency (SCID) D) adrenoleukodystrophy Take your best guess and write it in the comments below 👇 #TuesdayTrivia #TriviaTuesday #FDA #genetherapy #clinicalresearch #innovation #consulting #FDAapprovals #raredisease

Happy Friday everyone! The answer to our Tuesday Trivia is ... 🥁 🥁 🥁 🥁 C! The FDA approved 55 novel drug therapies in 2023. You can find the full list of approvals HERE: https://lnkd.in/ew7mEvBe Another fun fact .. so far, there have been 29 novel drug approvals in 2024. Stay tuned for next week's Tuesday Trivia. We hope we will have more participation next week! #TuesdayTrivia #FDAApprovals #clinicalresearch #TheMoreYouKnow #GSCTS #GSClinical

📅 IT'S TRIVIA TUESDAY AGAIN! 📅 Let's see if you can guess this one! How many new drugs did the FDA approve in 2023? A) 43 B) 78 C) 55 D) 28 Drop your answers in the comments below! ⬇️ Check back on Friday to find out the correct answer! #TriviaTuesday #FDAApprovals #ClinicalResearch #DrugDevelopment #HealthcareInnovation #GSClinical #GSCTS

🥁 Trivia Tuesday Reveal! 🥁 🤓 We asked: What was the first drug to get approved under the modern FDA regulations in 1938? 💡 Here’s a quick recap of the options: A: Aspirin B: Penicillin C: Cimetidine D: Sulfanilamide And the answer is… D: Sulfanilamide! That’s right! Sulfanilamide was the first drug to receive approval under the Federal Food, Drug, and Cosmetic Act, marking a significant milestone in the history of FDA regulation. 🏛️ We hope you enjoyed this little dive into FDA history as much as we did. Stay tuned for more trivia and fun facts! #TriviaTuesday #FDA #ClinicalResearch #GSCTS #FunFact #DrugHistory

🌟 Trivia Tuesday Time! 🌟 Let’s dive into a bit of FDA history! 🤓 Did you know? What was the first drug to get approved under the modern FDA regulations? 💡 HINT: It was approved the very same year that the Federal Food, Drug, and Cosmetic Act was enacted... in 1938! A: Aspirin B: Penicillin C: Cimetidine D: Sulfanilamide Comment BELOW 👇 with what you think it is! And be sure to tune in tomorrow for the answer! 😎 👉 #TriviaTuesday #FDA #clinicalresearch #GSCTS #FunFact #DrugHistory

🤖 AI Revolutionizing Clinical Trials! 🤖 Last week, we had the pleasure of attending the FDA's workshop on Artificial Intelligence in drug and biological product development. Did you know that artificial intelligence (AI) is transforming the landscape of clinical trials? Recent advancements are showing how AI can streamline processes, enhance data analysis, and improve patient outcomes. For example, AI algorithms are now being used to identify suitable candidates for trials more efficiently by analyzing vast datasets and predicting patient responses. This not only speeds up recruitment but also ensures a better match between patients and trials, leading to more accurate and reliable results. AI is also revolutionizing data analysis by uncovering patterns that might be missed by traditional methods. This allows researchers to gain deeper insights and make more informed decisions throughout the trial process. At GS Clinical, we’re excited about the potential of AI to drive innovation and efficiency in clinical research. How do you think AI will shape the future of clinical trials? Check out this paper by the FDA ""Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together" that discusses the FDA's efforts to incorporate AI safely. #AI #ClinicalTrials #MedicalResearch #Innovation #HealthcareTech #GSCTS #clinicalresearch #consulting

We understand that the road to bringing innovative treatments to market is complex, and we’re here to make that journey smoother for our clients. From study design and site selection to patient recruitment and regulatory compliance, our dedicated team provides end-to-end solutions tailored to the unique needs of each trial. Let’s connect and explore how we can support your next breakthrough!